Orchid Chemical to acquire US marketing company
June 10th, 2010 - 6:41 pm ICT by IANSChennai, June 10 (IANS) City-based drug maker Orchid Chemicals and Pharmaceuticals announced Thursday it will acquire a US-based generic drug marketing company, Karalex Pharma, this month.
According to Orchid Chemicals, the all cash transaction is expected to be completed by this month. Karalex Pharma is headquartered in New Jersey.
With this acquisition, Orchid Chemicals will be able to reach its
generic drugs to the US market.
“This acquisition will provide a strong commercial US-based sales capability to Orchid, paving the way for synergistic
returns from our upcoming and long-term strategic generic pharmaceuticals pipeline,” Managing Director K. Raghavendra Rao said in a statement.
- Orchid Pharma to invest Rs.200 crore in niche segment - Nov 04, 2010
- Orchid Chemicals completes business transfer to Hospira - Mar 31, 2010
- Orchid Chemicals signs out-licensing deal with Alvogen - May 05, 2010
- Orchid Chemicals completes business transfer to Hospira - Mar 31, 2010
- Orchid Chemicals to pay off debt by selling business - Dec 16, 2009
- Orchid Chemicals' plant shut on pollution concerns - Jul 11, 2011
- Decks cleared for Orchid to market anti-infectives in US - Sep 25, 2009
- Hospira eyeing Indian partners to make medical devices - Dec 17, 2009
- Orchid Chemicals sells 'pearl' to Hospira - Dec 16, 2009
- US health regulator approves Chennai drug plant - Jun 22, 2011
- Surya Pharma's arm acquires US's ActivOn for $22 mn - Dec 28, 2010
- Dr.Reddy's acquires JB Chemicals business in Russia - Jul 23, 2011
- Indian drug major Sun Pharma takes control of Israeli Taro - Sep 22, 2010
- Ranbaxy settles issue with US health regulator - Dec 21, 2011
- Orchid Chemicals to invest Rs.200 crore this fiscal - Jul 29, 2011
Tags: acquisition, capability, cash transaction, drug marketing, generic drug, generic drugs, generic pharmaceuticals, managing director, marketing company, orchid chemicals, paving the way, pipeline, raghavendra rao